Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:937 (4 November), doi:10.1136/bmj.333.7575.937-a
Quebec David Spurgeon
Ethical and philosophical arguments against the sale of organs for transplantation are difficult to sustain when scrutinised closely, says a University of Toronto professor of public health and surgery in an article entitled “The case for a regulated system of living kidney sales” (Nature Clinical Practice Nephrology 2006;2:600-1).
Abdallah Daar, director of ethics and policy for the McLaughlin Centre for Molecular Medicine and co-director of the Canadian Program on Genomics and Global Health, says he and colleagues in the International Forum for Transplant Ethics do not argue that organ sales are always acceptable or that the market should be unfettered: “Our claim is that none of the familiar arguments against organ selling work, and this allows for the possibility that better arguments may be found.”
“In the US 90 000 patients are on the waiting list of whom 6000 die every year; in cities, there is a
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses